Beta Bionics, Inc. - Common Stock, par value $0.0001 per share (BBNX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
BBNX on Nasdaq
Shares outstanding
44,038,904
Price per share
$14.93
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
47,217,206
Total reported value
$1,439,097,650
% of total 13F portfolios
0%
Share change
-1,179,677
Value change
+$22,267,305
Number of holders
156
Price from insider filings
$14.93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beta Bionics, Inc. - Common Stock, par value $0.0001 per share (BBNX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EVENTIDE ASSET MANAGEMENT, LLC 11% $52,456,043 4,857,041 Eventide Asset Management, LLC 31 Jan 2025
Farallon Capital Partners, L.P. 9.9% +2% $88,211,589 +$3,544,640 4,379,920 +4.2% Dapice Joshua J. 31 Dec 2025
Zone Healthcare Holdings, LLC 9.9% +25% $85,717,590 +$17,618,729 4,313,920 +26% Dapice Joshua J. 30 Sep 2025
MORGAN STANLEY 8.6% +26% $74,305,196 +$16,109,185 3,739,567 +28% Morgan Stanley 30 Sep 2025
Sands Capital Life Sciences Pulse Fund II, L.P. 8.2% +13% $48,410,732 +$5,636,946 3,570,113 +13% Sands Capital Life Sciences Pulse Fund II. L.P. 30 Jun 2025
BlackRock, Inc. 6.4% $55,215,708 2,778,764 BlackRock, Inc. 30 Sep 2025
RTW INVESTMENTS, LP 5.7% -24% $50,350,000 -$16,109,362 2,500,000 -24% RTW Investments, LP 31 Dec 2025
Point72 Asset Management, L.P. 5.2% $34,190,043 2,290,023 Point72 Asset Management, L.P. 18 Feb 2026
VANGUARD GROUP INC 5.1% $44,035,596 2,216,185 The Vanguard Group 30 Sep 2025
PERCEPTIVE ADVISORS LLC 3.7% $21,609,324 1,593,608 Perceptive Advisors LLC 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 1.8% -70% $15,835,993 -$29,602,207 796,964 -65% Millennium Management LLC 30 Sep 2025

As of 31 Dec 2025, 156 institutional investors reported holding 47,217,206 shares of Beta Bionics, Inc. - Common Stock, par value $0.0001 per share (BBNX). This represents 107% of the company’s total 44,038,904 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Beta Bionics, Inc. - Common Stock, par value $0.0001 per share (BBNX) together control 90% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
EVENTIDE ASSET MANAGEMENT, LLC 11% 4,994,728 +0.76% 2.4% $152,232,937
FARALLON CAPITAL MANAGEMENT LLC 9.8% 4,313,920 0% 0.76% $131,445,142
Sands Capital Alternatives, LLC 8.1% 3,570,113 0% 21% $108,781,343
MORGAN STANLEY 7.9% 3,459,453 -8% 0.01% $105,409,532
BlackRock, Inc. 6.6% 2,913,920 +4.8% 0% $88,787,143
Soleus Capital Management, L.P. 5.8% 2,534,565 -35% 3.3% $77,228,196
RTW INVESTMENTS, LP 5.7% 2,500,000 -24% 0.76% $76,175,000
VANGUARD GROUP INC 5% 2,218,238 +0.09% 0% $67,589,712
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 3% 1,327,100 0.07% $40,436,737
Omega Fund Management, LLC 3% 1,316,183 -31% 14% $40,104,096
Point72 Asset Management, L.P. 2.2% 987,351 0.05% $30,084,585
Driehaus Capital Management LLC 2.2% 956,784 -9.6% 0.2% $29,153,208
MILLENNIUM MANAGEMENT LLC 2.1% 945,461 +19% 0.02% $28,808,197
DEERFIELD MANAGEMENT COMPANY, L.P. 2.1% 938,308 -20% 0.37% $28,590,245
GEODE CAPITAL MANAGEMENT, LLC 2.1% 921,464 +0.43% 0% $28,083,886
STATE STREET CORP 2% 863,133 +4.5% 0% $26,299,663
Eversept Partners, LP 1.5% 678,262 1.2% $20,666,643
Walleye Capital LLC 1.5% 646,539 +9.4% 0.11% $19,700,043
PERCEPTIVE ADVISORS LLC 1.4% 602,944 +117% 0.34% $18,371,704
Vestal Point Capital, LP 1.4% 600,000 0% 0.67% $18,282,000
12 West Capital Management LP 1.3% 575,000 2.1% $17,520,250
PRICE T ROWE ASSOCIATES INC /MD/ 1.2% 532,749 +9.2% 0% $16,233,000
BANK OF AMERICA CORP /DE/ 0.98% 432,340 +119% 0% $13,173,400
LORD, ABBETT & CO. LLC 0.98% 430,403 +18% 0.04% $13,114,000
TWO SIGMA INVESTMENTS, LP 0.93% 410,603 +151% 0.02% $12,511,073

Institutional Holders of Beta Bionics, Inc. - Common Stock, par value $0.0001 per share (BBNX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 47,217,206 $1,439,097,650 +$22,267,305 $30.47 156
2025 Q3 48,310,134 $959,915,542 +$85,339,869 $19.87 127
2025 Q2 44,848,348 $652,883,600 +$53,846,940 $14.56 114
2025 Q1 41,702,710 $507,967,865 +$504,374,335 $12.24 102